- GROUP Survivorship
- PROJECT SPAN 2020
- DATE 01/01/2020
Carolyn Mazariego
COSA established its Survivorship Research Fellowship program in 2020, and appointed three early career researchers to lead research studies that would help build capacity in survivorship research. The Fellows received mentorship, guidance and support from the Survivorship Executive Committee, which comprises internationally renowned senior clinicians and researchers in cancer survivorship. Each project will help advance survivorship research and improve outcomes for all Australians after cancer treatment.
The Project
Priority recommendations for the implementation of patient-reported outcomes in clinical cancer care: A Delphi study Journal of Cancer Survivorship 2022
The aim of this study was to develop priority recommendations for the service level implementation of patient reported outcomes (PROs) into clinical cancer care.
Development of draft guidance statements was informed by a literature review, the Knowledge to Action (KTA) implementation framework, and discussion with PRO experts and cancer survivors. A two-round modified Delphi survey with key stakeholders including cancer survivors, clinical and research experts, and Information Technology specialists was undertaken. Round 1 rated the importance of the statements and round 2 ranked statements in order of priority.
Round 1 was completed by 70 participants with Round 2 completed by 45 participants. Forty-seven statements were rated in Round 2. In Round 1, highest agreement items (>90% agreement) included those that focused on the formation of strong stakeholder partnerships, ensuring ongoing communication within these partnerships, and the use of PROs for improvement and guidance in clinical care. Items ranked as the highest priorities in Round 2 included assessment of current staff capabilities and service requirements, mapping of workflows and processes to enable collection, and using collected PROs to guide improved health outcomes.
This stakeholder consultation process has identified key priorities in PRO implementation into clinical cancer care that include: clinical relevance, stakeholder engagement, communication, and integration within the existing processes and capabilities.
(Abstract126)
View poster
Top 5 most highly prioritised statements within each Knowledge To Action domain to consider when attempting to implement PROs into routine clinical cancer care practice
“In order to facilitate the routine collection of PROs within a health service, the health service should…”
Related projects
Survivorship
Financial Toxicity Working Group
Survivorship
Survivorship Research Fellow - Julia Morris
Survivorship
Patient Reported Outcomes (PRO) Working Group
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 2 days ago
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: bit.ly/3BwXvwL
Read More >COSAoncology 3 days ago
COSA is pleased to be a regional partner for ASCO Breakthrough, 8-10 August 2024, Yokohama, Japan, and online. Earlybird registration closes 26 June: bit.ly/4dFGiDJ #ASCOBT24
Read More >COSAoncology 5 days ago
RT by @cosaoncology: 🚨Last Chance to Register🚨 Don't miss the opportunity to: 👩⚕️Enhance your understanding of survivorship care in people with treatable but not curable cancers 💡Discover strategies for improving patient outcomes. Register here tinyurl.com/yc89zvmk #survonc #cancernurses
Read More >COSAoncology 10 days ago
Congratulations COSA Exercise & Cancer Group Chair @davemiz_EP. Wonderful to see such well-deserved recognition!
Read More >COSAoncology 16 days ago
RT by @cosaoncology: 👁️ The 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit program is now available! 5 International speakers 11 Australian #ocularmelanoma experts 4 Ocular melanoma consumers Sat 15 June - Registration is free! Watch from anywhere worldwide! masc.org.au/aoma-summit/
Read More >COSAoncology 18 days ago
RT by @cosaoncology: 🚨Survivorship Care for People affected by Advanced or Metastatic Cancer🚨 💥 MASCC-ASCO Standards / Practice Recommendations now published💥 ‼️ Clinical tools online ‼️ 14 languages (coming soon) Co-published open access: ascopubs.org/doi/full/10.12… and link.springer.com/article/10.100…
Read More >COSAoncology 19 days ago
Last chance to save! Join or renew your COSA membership before 30 April 2024 to secure the 2023 member rate before they increase for 2024: bit.ly/3hXsDLm
Read More >COSAoncology 22 days ago
Missed the earlybird pricing for the COSA Cancer Pharmacists Group Education Program? You can still save if you join COSA or renew your membership before 30 April 2024! Members save on CPG registration fees - bit.ly/3aNqaSr
Read More >COSAoncology 22 days ago
COSA Groups create spaces to share ideas and information, work on projects and research, and contribute to COSA Council. To stay updated, make sure you update your Groups preferences when you renew your COSA membership. More: bit.ly/3emnboq
Read More >COSAoncology 24 days ago
RT by @cosaoncology: 🎙️Join Kim Hobbs at the Redefining Survivorship webinar! From navigating uncertainty to addressing financial burden and psychological challenges, Kim will offer invaluable advice for supporting people with treatable, but not curable cancers. Register here: tinyurl.com/yc89zvmk
Read More >